WHO recommends rescheduling cannabis provides clarity on CBD Member states of the United Nations Commission on Narcotic Drugs (CND) received the World Health Organization Expert Committee on Drug Dependence’s (ECDD) cannabis recommendations, which had been expected in December, Marijuana Business Daily has learned.
The CND had been expected to consider rescheduling cannabis in March 2019 at its annual meeting, but the delay in receiving the ECDD recommendations may push that consideration into 2020 to provide additional time for member states to review them.
The report recommends several changes to how cannabis is scheduled, which could have significant implications for the cannabis industry:
The scheduling of cannabis in the international drug control conventions wouldn’t be as restrictive as it is now, because it would be removed from Schedule IV of the 1961 Convention, the category reserved for the most dangerous substances.
THC in all forms would be removed from the 1971 Convention and placed with cannabis in Schedule I of the 1961 Convention, significantly simplifying cannabis classification.
Pure CBD and CBD preparations containing no more than 0.2% THC would not be included in any way in the international drug control conventions.
Pharmaceutical preparations containing 9-THC, if they follow certain criteria, would be added to Schedule III of the 1961 Convention, recognizing the unlikelihood of abuse.
MJBizDaily obtained and reviewed a copy of the recommendations – which have not yet been made public – on how to schedule different categories of cannabis and cannabis-related substances. Those changes include:
• Cannabis and cannabis resin
The report recommends cannabis and cannabis resin “be deleted from Schedule IV of the Single Convention on Narcotics Drugs (1961).”
https://mjbizdaily.com/world-health-organization-rescheduling-cannabis-clarity-cbd/